Congruence Therapeutics, a pioneering biotechnology company focused on developing novel small molecule correctors, has successfully closed a significant $39.5 million…
Read More
Congruence secures $39.5m to advance small molecule correctors pipeline
Science News: A Century of Empowering Public Understanding of Science
Since its inception in 1921, Science News has stood as a beacon of independent, nonprofit journalism, dedicated to delivering accurate…
Read More
Koala Genetic Renaissance: Rapid Growth Offers Hope for Restoring Lost Diversity
A groundbreaking genomic study of Australia’s iconic koala populations has unveiled a surprising and potentially vital mechanism for wildlife recovery:…
Read More
Molecular Switch FLI-1 Identified as Essential Regulator for Blood Stem Cell Activation and Enhanced Regenerative Medicine
In a significant advancement for the field of hematology and regenerative medicine, researchers at Weill Cornell Medicine have identified a…
Read More
First-of-its-Kind Implant Promises Dramatic Improvement for Severe Tissue Loss Treatment
An international research consortium, spearheaded by the renowned Levenberg Laboratory at the Technion-Israel Institute of Technology, has unveiled a groundbreaking,…
Read More
SLAS 2026: Orchestration platforms, API-first instruments and the rise of semiautonomous labs
The annual SLAS International Conference and Exhibition, held in Boston from February 7-11, 2026, served as a pivotal moment for…
Read More
New Research Identifies Tanycytes as Critical Gatekeepers in the Clearance of Toxic Tau Proteins Associated with Alzheimer’s Disease
The accumulation of tau protein within the neural architecture has long been recognized as a definitive pathological hallmark of Alzheimer’s…
Read More
Breakthrough in Osmotic Energy Harvesting EPFL Researchers Utilize Lipid-Coated Nanopores to Triple Blue Energy Efficiency
Researchers at the Ecole Polytechnique Fédérale de Lausanne (EPFL) have announced a significant leap in the field of renewable energy…
Read More
Wegovy HD Receives FDA Approval Amidst Looming Patent Expiries in Key Markets
The U.S. Food and Drug Administration (FDA) has granted approval for a higher-dose formulation of Novo Nordisk’s blockbuster weight-loss medication,…
Read More
Google DeepMind Unveils SynthID: A Groundbreaking Solution for AI Content Provenance and Combating Synthetic Media Misinformation
In an era increasingly defined by the proliferation of sophisticated artificial intelligence, Google DeepMind has introduced SynthID, a cutting-edge framework…
Read MoreYOU MAY HAVE MISSED
